Literature DB >> 11417605

Neurologic course of congenital disorders of glycosylation.

P L Pearl1, D Krasnewich.   

Abstract

Congenital disorders of glycosylation, formerly called carbohydrate-deficient glycoprotein syndrome, may present in infancy with slowly progressive neurologic deficits including cognitive impairment, ataxia, pigmentary retinal degeneration, and neuropathy. The metabolic defect is in N-linked oligosaccharide synthesis, and diagnosis is made by a serum transferrin isoelectric focusing. We reviewed the neurologic course of 10 children with congenital disorders of glycosylation (ages 13 months to 7 years). All had severe developmental delay and ataxia; none walked unassisted, and the highest level of communication was simple sign language in one patient. Five of 10 children had seizures (absence, complex partial, tonic clonic). Only one patient has had strokelike episodes, despite reports that they are common in this population. The underlying basis of these episodes has been hypothesized to be coagulopathy due to dysfunctional, incorrectly glycosylated coagulation factors. This 5-year-old patient with congenital disorders of glycosylation type Ia had two strokelike episodes, with evolving hemiparesis over 5 to 6 days' duration, followed by focal tonic-clonic seizures. Coagulation studies were normal. Electroencephalography showed transient hemispheric polymorphous delta-range slowing and suppression. Magnetic resonance imaging revealed corresponding cortical swelling. Magnetic resonance angiography was normal. Magnetic resonance spectroscopy revealed a decrease in the N-acetylaspartate peak, suggesting neuronal loss, with normal lactate peak. The neuroradiologic data do not support a thrombotic, embolic, or hemorrhagic basis for strokelike episodes in carbohydrate-deficient glycoprotein syndrome; other mechanisms must be considered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11417605     DOI: 10.1177/088307380101600604

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

1.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

2.  The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type 1a.

Authors:  P Feraco; M Mirabelli-Badenier; M Severino; M G Alpigiani; M Di Rocco; R Biancheri; A Rossi
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-21       Impact factor: 3.825

3.  Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly.

Authors:  Andrew R Ednie; Eric S Bennett
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

4.  5- and 6-glycosylation of transferrin in patients with Alzheimer's disease.

Authors:  Susan J van Rensburg; Peter Berman; Felix Potocnik; Pam MacGregor; Dinie Hon; Nico de Villiers
Journal:  Metab Brain Dis       Date:  2004-06       Impact factor: 3.584

Review 5.  Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.

Authors:  Kavitha Siva; Giuseppina Covello; Michela A Denti
Journal:  Nucleic Acid Ther       Date:  2014-02       Impact factor: 5.486

6.  Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy.

Authors:  Mercè Izquierdo-Serra; Antonio F Martínez-Monseny; Laura López; Julia Carrillo-García; Albert Edo; Juan Darío Ortigoza-Escobar; Óscar García; Ramón Cancho-Candela; M Llanos Carrasco-Marina; Luis G Gutiérrez-Solana; Daniel Cuadras; Jordi Muchart; Raquel Montero; Rafael Artuch; Celia Pérez-Cerdá; Belén Pérez; Belén Pérez-Dueñas; Alfons Macaya; José M Fernández-Fernández; Mercedes Serrano
Journal:  Int J Mol Sci       Date:  2018-02-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.